Article info

Download PDFPDF
Non-selective beta-blocker use in cirrhosis: the additional benefit in preventing secondary infections

Authors

  • Rooshi Nathwani Division of Digestive Diseases, Imperial College London, London, UK Department of Metabolism, Digestion and Reproduction, Imperial College Healthcare NHS Trust, London, UK PubMed articlesGoogle scholar articles
  • David Kockerling Division of Digestive Diseases, Imperial College London, London, UK Department of Metabolism, Digestion and Reproduction, Imperial College Healthcare NHS Trust, London, UK PubMed articlesGoogle scholar articles
  • Benjamin H Mullish Division of Digestive Diseases, Imperial College London, London, UK Department of Metabolism, Digestion and Reproduction, Imperial College Healthcare NHS Trust, London, UK PubMed articlesGoogle scholar articles
  • Alexander Cole Division of Digestive Diseases, Imperial College London, London, UK Department of Metabolism, Digestion and Reproduction, Imperial College Healthcare NHS Trust, London, UK PubMed articlesGoogle scholar articles
  • Maud Lemoine Division of Digestive Diseases, Imperial College London, London, UK Department of Metabolism, Digestion and Reproduction, Imperial College Healthcare NHS Trust, London, UK PubMed articlesGoogle scholar articles
  • Charalambos Gustav Antoniades Division of Digestive Diseases, Imperial College London, London, UK Department of Metabolism, Digestion and Reproduction, Imperial College Healthcare NHS Trust, London, UK PubMed articlesGoogle scholar articles
  • Mark R Thursz Division of Digestive Diseases, Imperial College London, London, UK Department of Metabolism, Digestion and Reproduction, Imperial College Healthcare NHS Trust, London, UK PubMed articlesGoogle scholar articles
  • Ameet Dhar Division of Digestive Diseases, Imperial College London, London, UK Department of Metabolism, Digestion and Reproduction, Imperial College Healthcare NHS Trust, London, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Rooshi Nathwani, Division of Metabolism, Digestion and Reproduction, Imperial College London, London W2 1NY, UK; rooshi.nathwani08{at}imperial.ac.uk
View Full Text

Citation

Nathwani R, Kockerling D, Mullish BH, et al
Non-selective beta-blocker use in cirrhosis: the additional benefit in preventing secondary infections

Publication history

  • Received February 17, 2021
  • Revised February 22, 2021
  • Accepted February 24, 2021
  • First published March 11, 2021.
Online issue publication 
December 07, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.